Quick Answer
Viridian Therapeutics, Inc.DE reported Shares Outstanding of 101.83 million shares for fiscal year 2025.
Viridian Therapeutics, Inc.DE Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 101.83M | +25.7% |
| 2024 | 80.99M | +50.0% |
| 2023 | 53.99M | +30.7% |
| 2022 | 41.31M | +72.7% |
| 2021 | 23.92M | +465.4% |
| 2020 | 4.23M | +82.1% |
| 2019 | 2.32M | -92.5% |
| 2018 | 30.84M | +36.7% |
| 2017 | 22.57M | +2606.8% |
| 2016 | 833,744 | +17.6% |
| 2015 | 709,024 | -81.3% |
| 2014 | 3.78M | — |
| 2013 | 0 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 82.23M | +3.8% | +0.7% |
| June 30, 2025 | 81.65M | +27.8% | +0.1% |
| March 31, 2025 | 81.59M | +27.9% | +0.7% |
| December 31, 2024 | 80.99M | +50.0% | +2.3% |
| September 30, 2024 | 79.18M | +81.2% | +24.0% |
| June 30, 2024 | 63.88M | +46.6% | +0.1% |
| March 31, 2024 | 63.80M | +48.2% | +18.2% |
| December 31, 2023 | 53.99M | +30.7% | +23.5% |
- Viridian Therapeutics, Inc.DE showed an increase of +25.7% in Shares Outstanding compared to the prior fiscal year.
- The most recent figure is from Viridian Therapeutics, Inc.DE’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: